Pentoxifylline as an Adjuvant Therapy in the Treatment of Pediatric Pneumonia; A New Perspective of an Old Drug
Condition(s):Pentoxifylline as an Adjunct Therapy in the Treatment of PneumoniaLast Updated:February 20, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Pentoxifylline as an Adjunct Therapy in the Treatment of PneumoniaLast Updated:February 20, 2024Not yet recruiting
Condition(s):Neonatal Late Onset SepsisLast Updated:June 22, 2022Recruiting
Condition(s):Lupus NephritisLast Updated:February 2, 2021Withdrawn
Condition(s):Dizziness; VertigoLast Updated:April 13, 2021Completed
Condition(s):Bipolar DepressionLast Updated:April 15, 2022Completed
Condition(s):Capsular ContracturesLast Updated:August 28, 2013Unknown status
Condition(s):Biliary AtresiaLast Updated:January 11, 2024Terminated
Condition(s):Chronic Kidney Disease stage3 and 4; Type 2 Diabetes MellitusLast Updated:February 7, 2019Unknown status
Condition(s):Anemia of Chronic Kidney DiseaseLast Updated:November 8, 2018Completed
Condition(s):Resistant Major DepressionLast Updated:September 7, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.